American Healthcare REIT EVP sells 2,000 shares

American Healthcare REIT, Inc. executive vice president, general counsel and secretary Mark E. Foster sold 2,000 shares of common stock in an open-market transaction at $48.32 per share.

Rhea-AI Filing Summary

American Healthcare REIT, Inc. executive vice president, general counsel and secretary Mark E. Foster sold 2,000 shares of common stock in an open-market transaction at $48.32 per share. After this sale, he directly holds 55,495 shares of the company’s stock.

The sale occurred on June 1, 2026 under a pre-established Rule 10b5-1 trading plan adopted on December 19, 2025. The transaction was also completed under an exception to a lock-up agreement tied to the company’s underwritten common stock offering that closed on May 22, 2026.

Insider Trade Summary 10b5-1

Net Seller: 2,000 shares

Net Sell 1 txn

Insider Foster Mark E.

Role EVP, GC & Secretary

Sold 2,000 shs ($97K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,000	$48.32	$97K

Holdings After Transaction: Common Stock — 55,495 shares (Direct)

Footnotes (2)

1. F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.
2. F2. The transaction described herein was made pursuant to an exception to a lock-up agreement between the Reporting Person and the underwriter of the Issuer's offering of shares of common stock that closed on May 22, 2026.

Key Figures

Shares sold: 2,000 shares Sale price: $48.32 per share Shares held after sale: 55,495 shares +2 more

5 metrics

Shares sold 2,000 shares Open-market sale on June 1, 2026

Sale price $48.32 per share Common stock transaction price

Shares held after sale 55,495 shares Direct ownership following transaction

10b5-1 plan adoption date December 19, 2025 Pre-arranged trading plan for this sale

Related offering close date May 22, 2026 Underwritten common stock offering tied to lock-up

Key Terms

Rule 10b5-1 trading plan, lock-up agreement, underwriter, open-market sale

4 terms

Rule 10b5-1 trading plan regulatory

"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

lock-up agreement regulatory

"The transaction described herein was made pursuant to an exception to a lock-up agreement between the Reporting Person and the underwriter"

A lock-up agreement is a contract that prevents company insiders and early investors from selling their shares for a fixed period after a stock sale, often after an initial public offering. It matters to investors because it temporarily limits the number of shares that can hit the market, which can keep the share price steadier; when the lock-up ends, a sudden increase in available shares can create extra volatility, revealing insiders’ confidence or lack thereof.

underwriter financial

"lock-up agreement between the Reporting Person and the underwriter of the Issuer's offering of shares of common stock"

An underwriter is a financial firm that evaluates, guarantees and helps sell a new security offering—such as a stock or bond—by buying the issue from the issuer and reselling it to investors or organizing the sale. Think of them as a bridge or safety net: they take on the risk, set the price, handle marketing and paperwork, and their work determines how much money a company can raise and how smoothly the offering reaches the market.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AHR executive Mark E. Foster report?

Mark E. Foster reported selling 2,000 shares of American Healthcare REIT common stock. The open-market sale occurred at $48.32 per share and was disclosed on Form 4, showing his updated post-transaction holdings and confirming it was executed under a pre-arranged trading plan.

How many American Healthcare REIT (AHR) shares does Mark E. Foster hold after the sale?

After the transaction, Mark E. Foster holds 55,495 shares of American Healthcare REIT common stock. This figure reflects his direct ownership following the 2,000-share open-market sale disclosed in the Form 4 filing for the June 1, 2026 transaction.

At what price did AHR executive Mark E. Foster sell his shares?

He sold 2,000 American Healthcare REIT common shares at $48.32 per share. This was an open-market sale reported on Form 4, providing investors with the exact price and share count for the June 1, 2026 insider transaction.

Was Mark E. Foster’s AHR share sale under a Rule 10b5-1 plan?

Yes. The filing states the transaction was effected under a Rule 10b5-1 trading plan adopted on December 19, 2025. Such pre-arranged plans automate trades and can reduce the significance of timing for interpreting insider activity.

How is the AHR insider sale related to the company’s lock-up agreement?

The Form 4 notes the sale was made under an exception to a lock-up agreement with the underwriter. That lock-up was connected to American Healthcare REIT’s common stock offering that closed on May 22, 2026, allowing this specific trade.

What role does Mark E. Foster hold at American Healthcare REIT (AHR)?

Mark E. Foster serves as executive vice president, general counsel and secretary of American Healthcare REIT. His position as a senior officer makes his equity transactions reportable on Form 4, giving public visibility into his trading activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 04:22 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foster Mark E.

(Last) (First) (Middle)

C/O AMERICAN HEALTHCARE REIT, INC.

18191 VON KARMAN AVE., STE. 300

(Street)

IRVINE CALIFORNIA 92612

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, GC & Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		S(1)(2)		2,000	D	$48.32	55,495	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.

2. The transaction described herein was made pursuant to an exception to a lock-up agreement between the Reporting Person and the underwriter of the Issuer's offering of shares of common stock that closed on May 22, 2026.

	/s/ MARK E. FOSTER	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)